• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Press release

Analyst Group: Analyst Group Comments on NOSA’s Launch on the Pharmacy Market in the Netherlands and Belgium

Nosa Plugs

Nosa Plugs AB (”Nosa Plugs” or ”the Company”) announced on 5 June 2026 that the Company has entered into a partnership with the distributor OTC Health & Beauty regarding the products Nozoil and Odor Control for the markets in the Netherlands and Belgium. The order value amounts to approximately SEK 1.4m and represents the first of several expected orders. The order concerns a launch with a leading pharmacy chain in Benelux, Kruidvat, with distribution to all of the chain’s approximately 1,000 stores in the Netherlands and 300 stores in Belgium, with the launch estimated to take place in September 2026.

In summary, Analyst Group views the launch in the Netherlands and Belgium as a positive development that confirms an establishment on two of the markets the Company itself has identified as prioritized, and which, through a capital efficient wholesaler and distributor model, provides broad pharmacy coverage via the region’s leading chain Kruidvat. Given that the Benelux region constitutes one of Europe’s largest and most developed consumer healthcare markets, Analyst Group assesses that a broad initial presence in the region represents an attractive platform for continued growth. Analyst Group assesses that a successful reception among end customers may pave the way for further orders and broadened distribution over time, which together with the continued rollout of Nozoil across additional markets constitutes important signals that support the Company’s continued geographic expansion and growth.


Read Analyst Group’s comment here


About Analyst Group: One of Sweden's leading equity research boutiques with focus on small and medium-sized listed companies.
Read more about Analyst Group
 
This is a press release from Analyst Group regarding the publication of a comment on Nosa Plugs. Readers may assume that Analyst Group has received compensation for making the comment. The Company has not been given an opportunity to influence the parts where Analyst Group has had opinions about the Company, future valuation or anything else that could be considered a subjective assessment.